Topic Archives: Maxim

Hepatitis with a C

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. His words and opinions are his own.] In A History of New York, Washington Irving opens chapter VIII thus: ”In which the author and reader…fall into a very grave and instructive discourse.” This may prove to be a more unleavened column than […]

Comments

  • Travis Johnson, Stock Gumshoe

    The stock markets have stayed open for lots of civil unrest and war in the past, but they have also closed sometimes. I...

  • Avatar

    Hello,Habari to rainonme, Maxim :Winner never quite and quiter never win. Your advise succor to a novice. How do you pi...

  • Avatar

    $ONTX UW LONG Onconova Therapeutics downgrade details -- to Hold at Maxim Group following Phase 3 INSPIRE trial ...

  • Avatar

    ONTX UW LONG : Onconova downgraded to Hold from Buy at Maxim Maxim says have to address their financial needs....

  • Avatar

    $ONCS Long October 19, 2017 12:58 EDT ONCS OncoSec data continues to build for Keytruda combination, says Maxi...

  • Avatar

    Long $ABEO Maxim Group raises their ABEO tgt to $35 from $17. The advances in the gene therapy space and the comp to...

  • SoGiAm

    8 Ways To Play The AI Boom 9:24 am ET September 26, 2017 (Benzinga) Investors hungry for pure-play artificial intell...

  • Avatar

    Would love your thoughts on Maxim Integrated Products Inc (NASDAQ:MXIM)...

  • Avatar

    MXIM [ Maxim ] is the featured stock-You really should subscribe to Profits Unlimited. I've made about 30 % on a 2 yr...

  • Avatar

    I second hydtec's sentiments. To paraphrase Churchill's maxim, "KBO, keep buggering on" or in your case blathering....

  • Avatar

    Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) was upgraded by analysts at Leerink Swann from a "market perform" rating t...

  • Avatar

    $ ATHX long Today, Maxim Group reiterated its Buy rating on Athersys (NASDAQ:ATHX). There are 3 buy ratings on the ...

  • JohnM

    No, Nochi presented at the Maxim Group - Haitong Securities Healthcare Investor and Partnering Conference on March 6 in ...

  • arch1

    leslie7 You are a realist and teller of truth,,, so expect retaliation. No good deed shall go unpunished,,, is a maxim t...

  • Dr. KSS MD PhD

    Hi Sam: Still pretty hard for me to enthuse about $CBAY when the market offers an absolute embarrassment of scientifi...

  • Avatar

    Arch is diving into the Chinese market! Arch Therapeutics to Provide Corporate Update at the Maxim Group - Haitong Se...

  • SoGiAm

    $ARTH long - Arch Therapeutics to Provide Corporate Update at the Maxim Group - Haitong Securities Healthcare Investor a...

  • Anamorph

    I wouldn't put too much stock (ha) in Rodman and Renshaw's coverage or price target. But nor would I lump it in with t...

  • JohnM

    Free Slingshots Insights Call Today - Listen Here or Replay Later http://slingshotinsights.us8.list-manage.com/track/cl...

  • arch1

    Lulu Truthtellers are often attacked. Be assured you will always be treated with respect here Military has a maxim that...

  • Avatar

    Hi mmdwacjm, I hear your pain but I guess it all depends what Arth means to you and hence, the patience you are willing ...

  • Anamorph

    Reuters are not an investment banking or brokerage firm and don't do analysis. They are a news service and have, like y...

  • Avatar

    Instead of $1.9 million series E exercised only $ 306,000 exercised---so $ 1.6 million Maxim investors have not exercise...

  • Avatar

    I read the 8K quickly and the loan payoff was triggered by the amount of capital they have raised over the last 12 month...

  • Avatar

    $400,000 monthly burn rate $ 5.7 million cash 6/30/16 per quarterly 10Q + 1.9 million exercise of series E warrant...

  • Dr. KSS MD PhD

    Thanks Phil. I really appreciate it and will pass those wishes on to him, too. There's an old maxim in medicine about ho...

  • Avatar

    Amen !! As I said yesterday the warrants by Maxim investors were not exercised as I had hoped. Perhaps they are doing th...

  • Avatar

    Mark Regarding scarring I believe that additives to AC5 will enhance healing also. My question is let's say you ha...

  • Avatar

    Thanks for that analysis re $ARTH Cleveland. I lot of research must have gone into it to get down to those details. I p...

  • Avatar

    I have not talked to him for awhile and I hope you do. I am not thrilled with Maxim being involved with Arch. Maxim ha...

  • Steve M

    Isn’t the idea to buy it right after the crash, which was down to 4.00 yesterday pre-market? With nimbleness one might...

  • Dr. KSS MD PhD

    Patrick: it's possible but I predict not. I think at interim it will be a close call favoring plazo and that they'll go-...

  • Avatar

    Benitec - Maxim Group was the underwriter for the Benitec equity....

  • Avatar

    I think this may be the classic example of why this group is referred to as "anal-ysts". Benitec Biopharma (NASDAQ:BN...

  • Avatar

    Interesting POV on why $EDIT went public a few days ago... hmm... some good points, and as Dr. K says... years away from...

  • Dr. KSS MD PhD

    Thanks! Honor Roll post....great and wise perspective. One can virtually hear you doing a Tibetan monk's deep breathing ...

  • Travis Johnson, Stock Gumshoe
  • Avatar

    Keep in mind that Maxim gets compensated for research note but a positive none the less. Green Light For Clinical Stu...

  • sogiam

    AVXL-The terrible trio Agora, Lincoln Park and Maxim Kolbert has pump-and-Dump claws into Anavex per Adam Feuerstein B...

  • Avatar

    Lulu/TomN: I think you guys are raising an important general point when you say 'a host of others'. KSS writes regularly...

  • Avatar

    In the Maxim Report that came out in April, it says they are looking for a partner. "The key for Arch, beyond regulat...

  • sogiam

    BLRX-Long: BioLineRx Investors: Expect 'Pivotal' Data In Next Few Weeks 9:53 am ET July 16, 2015 (Benzinga) Print In a...

  • Avatar

    $ARTH: So what “unofficial seals of approval” do we have so far in Gummie Land? 1) Dr KSS’s science – yes 2) ...

  • Avatar

    Norchi told me that revenues for a 2cm by 2cm area should be approximately $400 to $ 500. I believe this was in the Maxi...

  • Avatar

    Maxim reaffirms BLRX buy at 8.00 target. http://www.dakotafinancialnews.com/maxim-group-reaffirms-buy-rating-for-biolin...

  • Avatar

    $OPEX - Maxim has a reputation of being overly zealous with their opinions as to where a stock price is heading. Their ...

  • Avatar

    Anyone know anything on this one , Opexa Therapeutics (OPEX)? Maxim put a 5.00 price target on them and this happened ye...

  • Avatar

    Mary I made a brief comment on brokers on bios yesterday-in my opinion Maxim is poor based on their past track record et...

  • Avatar

    Maxim group seems to like several of the stocks we follow---does anyone know anything about their accuracy?...

  • Avatar

    now we have a biotech pop coming this am from the unreal premium paid for Geva-orphan drugs to the moon-it is no coincid...

  • Avatar

    Roth gives BLRX 10.50 price target and Maxim a 8.00 target as well.That would be a sweet move. http://www.wkrb13.com/ma...

  • Avatar

    In the sea of red,hope for those who hold NBY. Coverage initiated by Maxim. http://finance.yahoo.com/news/maxim-rates-n...

  • Avatar

    ARTH according to the Maxim report....Arch Finances. Arch Therapeutics ended 2014 (FYE September 30) with $834K in cash ...

  • Avatar

    Okay,my daughter got me through on how to post the Maxim Research on ARTH. Here it is,hope it works or I will blame her...

  • Avatar

    Glenn - - i believe that you already have my email info. If so, can you please forward me that Maxim report on ARTH. T...

  • Avatar

    Doc,I forwarded you the Maxim Coverage on ARTH to your email and posted the link on the recent Norchi interview. Cheers...

  • Avatar

    Parick, I did watch and things seem to be heating up with them.The Curam deal was already in place but they are still wa...

  • Avatar

    Trying once again, if this does not work I will get my daughter later to show me how or you can forward me your email th...

  • Avatar

    Maxim starts Arch Therapeutics (ARTH) at 3.00 target.Very nice research report. Download File:ARTH initiation Maxim Apr...

  • Avatar

    Some good news for one of our stocks, although not sure how much it matters: $BLUE is now covered by analysts at Maxim G...

  • Subramania

    $BLUE raised to $190 at Maxim. $HALO raised to $21 at Citi....

  • Avatar

    Got an answer from NBY. ""If you recall, we did a financing with Maxim Securities last month in which we sold un-regist...

  • Avatar

    $TROV Maxim Group raised their target price from $10 to $13. http://www.wkrb13.com/markets/558987/maxim-group-boosts...

  • Avatar

    Tim, I am not trying to rain on your parade or ATNM in which I have a minor position but price targets on bios are often...

  • Avatar

    ACHN Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) was given a new $22.00 price target on by analysts at Maxim Group. T...

  • Avatar

    One we have kicked around here before Foamix (FOMX) made a big time move Friday. http://finance.yahoo.com/q?s=FOMX Th...

  • Avatar

    Maxim maintains buy on ACHN and target of 22.00 today. http://www.smarteranalyst.com/2014/11/05/maxim-maintains-buy-on-...

  • Dr. KSS, MD PhD

    Steve: great question. (1) I never know what to make of ratings by stock analysts. Some, like Zack's and Maxim, seem...

  • Dr. KSS, MD PhD

    Linda: I don't think his resig is the reason. He was, to my mind, the absolutely least relevant person on the board. His...

  • Dr. KSS, MD, PhD

    As I see it, and I am just being honest, CytRx could easily be renamed Junk-A-Junk Chemo. Aldoxorubicin is to doxorubici...

  • Avatar

    HI , JUST QUICK WORD - Benetec seems be fine On 15/4 it completed prev. announced Private placement of 29.4Ms...

  • Avatar

    Since many here are Benitec investors or followers (I believe Dr KSS introduced Benitec to gumshoes from what ive read) ...

  • Dr. KSS, MD PhD

    As regards Tonix, I have posted many negative things about this company since January, and believe that the fall in shar...

  • Avatar

    Sell in May and go away, come back on St Leger day (that's a decades old London Stock Exchange maxim). There. I've saved...

  • Avatar

    Hi. I am a circuit designer in the analog field. LTC is indeed a leader as are National Semi, Texas Instruments, Analog...

  • Avatar

    Linear Tech was about the best company in the IC business until about 2005. Since then, they've had trouble growing and...

  • This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.

    Connect with Travis

    website designed by Gravity Switch